Clinical Trial Logistics Market Size, Share & Growth Report by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Clinical Trial Logistics Market Size Analysis

Global Clinical Trial Logistics Market Introduction
By Service
1. Introduction
  1. Service By Value
2. Transportation
  1. By Value
  2. Road
    1. Road By Value
  3. Air
    1. Air By Value
  4. Others
    1. Others By Value
3. Warehousing & Distribution
  1. By Value
4. Value-Added Services (Labelling, Kitting, QP Release)
  1. By Value
By Clinical Phase
1. Introduction
  1. Clinical Phase By Value
2. Phase I
  1. By Value
3. Phase II
  1. By Value
4. Phase III
  1. By Value
5. Phase IV / post-marketing
  1. By Value
By Therapeutic Area
1. Introduction
  1. Therapeutic Area By Value
2. Oncology
  1. By Value
3. Cardiovascular Diseases
  1. By Value
4. Rare / Orphan Diseases
  1. By Value
5. Immunology & Inflammation
  1. By Value
6. Endocrine & Metabolic Disorders
  1. By Value
7. Neurology & Psychiatry
  1. By Value
8. Others
  1. By Value
By End-user
1. Introduction
  1. End-user By Value
2. Bio-Pharma Manufacturers
  1. By Value
3. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
  1. By Value
4. Hospitals & Clinical-Trial Sites
  1. By Value
5. Other End Users
  1. By Value
By Temperature Range
1. Introduction
  1. Temperature Range By Value
2. Cold Chain
  1. By Value
  2. Ambient (15-25 °C)
    1. Ambient (15-25 °C) By Value
  3. Refrigerated (2–8 °C)
    1. Refrigerated (2–8 °C) By Value
  4. Frozen (0 °C to -20 °C)
    1. Frozen (0 °C to -20 °C) By Value
  5. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    1. Ultra-Cold / Cryogenic (-20 °C to -150 °C) By Value

North America Market Analysis

Introduction
By Service
1. Introduction
  1. Service By Value
2. Transportation
  1. By Value
  2. Road
    1. Road By Value
  3. Air
    1. Air By Value
  4. Others
    1. Others By Value
3. Warehousing & Distribution
  1. By Value
4. Value-Added Services (Labelling, Kitting, QP Release)
  1. By Value
By Clinical Phase
1. Introduction
  1. Clinical Phase By Value
2. Phase I
  1. By Value
3. Phase II
  1. By Value
4. Phase III
  1. By Value
5. Phase IV / post-marketing
  1. By Value
By Therapeutic Area
1. Introduction
  1. Therapeutic Area By Value
2. Oncology
  1. By Value
3. Cardiovascular Diseases
  1. By Value
4. Rare / Orphan Diseases
  1. By Value
5. Immunology & Inflammation
  1. By Value
6. Endocrine & Metabolic Disorders
  1. By Value
7. Neurology & Psychiatry
  1. By Value
8. Others
  1. By Value
By End-user
1. Introduction
  1. End-user By Value
2. Bio-Pharma Manufacturers
  1. By Value
3. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
  1. By Value
4. Hospitals & Clinical-Trial Sites
  1. By Value
5. Other End Users
  1. By Value
By Temperature Range
1. Introduction
  1. Temperature Range By Value
2. Cold Chain
  1. By Value
  2. Ambient (15-25 °C)
    1. Ambient (15-25 °C) By Value
  3. Refrigerated (2–8 °C)
    1. Refrigerated (2–8 °C) By Value
  4. Frozen (0 °C to -20 °C)
    1. Frozen (0 °C to -20 °C) By Value
  5. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    1. Ultra-Cold / Cryogenic (-20 °C to -150 °C) By Value
U.S.
1. By Service
  1. Introduction
    1. Service By Value
  2. Transportation
    1. By Value
    2. Road
      1. Road By Value
    3. Air
      1. Air By Value
    4. Others
      1. Others By Value
  3. Warehousing & Distribution
    1. By Value
  4. Value-Added Services (Labelling, Kitting, QP Release)
    1. By Value
2. By Clinical Phase
  1. Introduction
    1. Clinical Phase By Value
  2. Phase I
    1. By Value
  3. Phase II
    1. By Value
  4. Phase III
    1. By Value
  5. Phase IV / post-marketing
    1. By Value
3. By Therapeutic Area
  1. Introduction
    1. Therapeutic Area By Value
  2. Oncology
    1. By Value
  3. Cardiovascular Diseases
    1. By Value
  4. Rare / Orphan Diseases
    1. By Value
  5. Immunology & Inflammation
    1. By Value
  6. Endocrine & Metabolic Disorders
    1. By Value
  7. Neurology & Psychiatry
    1. By Value
  8. Others
    1. By Value
4. By End-user
  1. Introduction
    1. End-user By Value
  2. Bio-Pharma Manufacturers
    1. By Value
  3. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
    1. By Value
  4. Hospitals & Clinical-Trial Sites
    1. By Value
  5. Other End Users
    1. By Value
5. By Temperature Range
  1. Introduction
    1. Temperature Range By Value
  2. Cold Chain
    1. By Value
    2. Ambient (15-25 °C)
      1. Ambient (15-25 °C) By Value
    3. Refrigerated (2–8 °C)
      1. Refrigerated (2–8 °C) By Value
    4. Frozen (0 °C to -20 °C)
      1. Frozen (0 °C to -20 °C) By Value
    5. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      1. Ultra-Cold / Cryogenic (-20 °C to -150 °C) By Value
Canada

Europe Market Analysis

Introduction
By Service
1. Introduction
  1. Service By Value
2. Transportation
  1. By Value
  2. Road
    1. Road By Value
  3. Air
    1. Air By Value
  4. Others
    1. Others By Value
3. Warehousing & Distribution
  1. By Value
4. Value-Added Services (Labelling, Kitting, QP Release)
  1. By Value
By Clinical Phase
1. Introduction
  1. Clinical Phase By Value
2. Phase I
  1. By Value
3. Phase II
  1. By Value
4. Phase III
  1. By Value
5. Phase IV / post-marketing
  1. By Value
By Therapeutic Area
1. Introduction
  1. Therapeutic Area By Value
2. Oncology
  1. By Value
3. Cardiovascular Diseases
  1. By Value
4. Rare / Orphan Diseases
  1. By Value
5. Immunology & Inflammation
  1. By Value
6. Endocrine & Metabolic Disorders
  1. By Value
7. Neurology & Psychiatry
  1. By Value
8. Others
  1. By Value
By End-user
1. Introduction
  1. End-user By Value
2. Bio-Pharma Manufacturers
  1. By Value
3. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
  1. By Value
4. Hospitals & Clinical-Trial Sites
  1. By Value
5. Other End Users
  1. By Value
By Temperature Range
1. Introduction
  1. Temperature Range By Value
2. Cold Chain
  1. By Value
  2. Ambient (15-25 °C)
    1. Ambient (15-25 °C) By Value
  3. Refrigerated (2–8 °C)
    1. Refrigerated (2–8 °C) By Value
  4. Frozen (0 °C to -20 °C)
    1. Frozen (0 °C to -20 °C) By Value
  5. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    1. Ultra-Cold / Cryogenic (-20 °C to -150 °C) By Value
U.K.
1. By Service
  1. Introduction
    1. Service By Value
  2. Transportation
    1. By Value
    2. Road
      1. Road By Value
    3. Air
      1. Air By Value
    4. Others
      1. Others By Value
  3. Warehousing & Distribution
    1. By Value
  4. Value-Added Services (Labelling, Kitting, QP Release)
    1. By Value
2. By Clinical Phase
  1. Introduction
    1. Clinical Phase By Value
  2. Phase I
    1. By Value
  3. Phase II
    1. By Value
  4. Phase III
    1. By Value
  5. Phase IV / post-marketing
    1. By Value
3. By Therapeutic Area
  1. Introduction
    1. Therapeutic Area By Value
  2. Oncology
    1. By Value
  3. Cardiovascular Diseases
    1. By Value
  4. Rare / Orphan Diseases
    1. By Value
  5. Immunology & Inflammation
    1. By Value
  6. Endocrine & Metabolic Disorders
    1. By Value
  7. Neurology & Psychiatry
    1. By Value
  8. Others
    1. By Value
4. By End-user
  1. Introduction
    1. End-user By Value
  2. Bio-Pharma Manufacturers
    1. By Value
  3. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
    1. By Value
  4. Hospitals & Clinical-Trial Sites
    1. By Value
  5. Other End Users
    1. By Value
5. By Temperature Range
  1. Introduction
    1. Temperature Range By Value
  2. Cold Chain
    1. By Value
    2. Ambient (15-25 °C)
      1. Ambient (15-25 °C) By Value
    3. Refrigerated (2–8 °C)
      1. Refrigerated (2–8 °C) By Value
    4. Frozen (0 °C to -20 °C)
      1. Frozen (0 °C to -20 °C) By Value
    5. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      1. Ultra-Cold / Cryogenic (-20 °C to -150 °C) By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Service
1. Introduction
  1. Service By Value
2. Transportation
  1. By Value
  2. Road
    1. Road By Value
  3. Air
    1. Air By Value
  4. Others
    1. Others By Value
3. Warehousing & Distribution
  1. By Value
4. Value-Added Services (Labelling, Kitting, QP Release)
  1. By Value
By Clinical Phase
1. Introduction
  1. Clinical Phase By Value
2. Phase I
  1. By Value
3. Phase II
  1. By Value
4. Phase III
  1. By Value
5. Phase IV / post-marketing
  1. By Value
By Therapeutic Area
1. Introduction
  1. Therapeutic Area By Value
2. Oncology
  1. By Value
3. Cardiovascular Diseases
  1. By Value
4. Rare / Orphan Diseases
  1. By Value
5. Immunology & Inflammation
  1. By Value
6. Endocrine & Metabolic Disorders
  1. By Value
7. Neurology & Psychiatry
  1. By Value
8. Others
  1. By Value
By End-user
1. Introduction
  1. End-user By Value
2. Bio-Pharma Manufacturers
  1. By Value
3. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
  1. By Value
4. Hospitals & Clinical-Trial Sites
  1. By Value
5. Other End Users
  1. By Value
By Temperature Range
1. Introduction
  1. Temperature Range By Value
2. Cold Chain
  1. By Value
  2. Ambient (15-25 °C)
    1. Ambient (15-25 °C) By Value
  3. Refrigerated (2–8 °C)
    1. Refrigerated (2–8 °C) By Value
  4. Frozen (0 °C to -20 °C)
    1. Frozen (0 °C to -20 °C) By Value
  5. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    1. Ultra-Cold / Cryogenic (-20 °C to -150 °C) By Value
China
1. By Service
  1. Introduction
    1. Service By Value
  2. Transportation
    1. By Value
    2. Road
      1. Road By Value
    3. Air
      1. Air By Value
    4. Others
      1. Others By Value
  3. Warehousing & Distribution
    1. By Value
  4. Value-Added Services (Labelling, Kitting, QP Release)
    1. By Value
2. By Clinical Phase
  1. Introduction
    1. Clinical Phase By Value
  2. Phase I
    1. By Value
  3. Phase II
    1. By Value
  4. Phase III
    1. By Value
  5. Phase IV / post-marketing
    1. By Value
3. By Therapeutic Area
  1. Introduction
    1. Therapeutic Area By Value
  2. Oncology
    1. By Value
  3. Cardiovascular Diseases
    1. By Value
  4. Rare / Orphan Diseases
    1. By Value
  5. Immunology & Inflammation
    1. By Value
  6. Endocrine & Metabolic Disorders
    1. By Value
  7. Neurology & Psychiatry
    1. By Value
  8. Others
    1. By Value
4. By End-user
  1. Introduction
    1. End-user By Value
  2. Bio-Pharma Manufacturers
    1. By Value
  3. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
    1. By Value
  4. Hospitals & Clinical-Trial Sites
    1. By Value
  5. Other End Users
    1. By Value
5. By Temperature Range
  1. Introduction
    1. Temperature Range By Value
  2. Cold Chain
    1. By Value
    2. Ambient (15-25 °C)
      1. Ambient (15-25 °C) By Value
    3. Refrigerated (2–8 °C)
      1. Refrigerated (2–8 °C) By Value
    4. Frozen (0 °C to -20 °C)
      1. Frozen (0 °C to -20 °C) By Value
    5. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      1. Ultra-Cold / Cryogenic (-20 °C to -150 °C) By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Service
1. Introduction
  1. Service By Value
2. Transportation
  1. By Value
  2. Road
    1. Road By Value
  3. Air
    1. Air By Value
  4. Others
    1. Others By Value
3. Warehousing & Distribution
  1. By Value
4. Value-Added Services (Labelling, Kitting, QP Release)
  1. By Value
By Clinical Phase
1. Introduction
  1. Clinical Phase By Value
2. Phase I
  1. By Value
3. Phase II
  1. By Value
4. Phase III
  1. By Value
5. Phase IV / post-marketing
  1. By Value
By Therapeutic Area
1. Introduction
  1. Therapeutic Area By Value
2. Oncology
  1. By Value
3. Cardiovascular Diseases
  1. By Value
4. Rare / Orphan Diseases
  1. By Value
5. Immunology & Inflammation
  1. By Value
6. Endocrine & Metabolic Disorders
  1. By Value
7. Neurology & Psychiatry
  1. By Value
8. Others
  1. By Value
By End-user
1. Introduction
  1. End-user By Value
2. Bio-Pharma Manufacturers
  1. By Value
3. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
  1. By Value
4. Hospitals & Clinical-Trial Sites
  1. By Value
5. Other End Users
  1. By Value
By Temperature Range
1. Introduction
  1. Temperature Range By Value
2. Cold Chain
  1. By Value
  2. Ambient (15-25 °C)
    1. Ambient (15-25 °C) By Value
  3. Refrigerated (2–8 °C)
    1. Refrigerated (2–8 °C) By Value
  4. Frozen (0 °C to -20 °C)
    1. Frozen (0 °C to -20 °C) By Value
  5. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    1. Ultra-Cold / Cryogenic (-20 °C to -150 °C) By Value
UAE
1. By Service
  1. Introduction
    1. Service By Value
  2. Transportation
    1. By Value
    2. Road
      1. Road By Value
    3. Air
      1. Air By Value
    4. Others
      1. Others By Value
  3. Warehousing & Distribution
    1. By Value
  4. Value-Added Services (Labelling, Kitting, QP Release)
    1. By Value
2. By Clinical Phase
  1. Introduction
    1. Clinical Phase By Value
  2. Phase I
    1. By Value
  3. Phase II
    1. By Value
  4. Phase III
    1. By Value
  5. Phase IV / post-marketing
    1. By Value
3. By Therapeutic Area
  1. Introduction
    1. Therapeutic Area By Value
  2. Oncology
    1. By Value
  3. Cardiovascular Diseases
    1. By Value
  4. Rare / Orphan Diseases
    1. By Value
  5. Immunology & Inflammation
    1. By Value
  6. Endocrine & Metabolic Disorders
    1. By Value
  7. Neurology & Psychiatry
    1. By Value
  8. Others
    1. By Value
4. By End-user
  1. Introduction
    1. End-user By Value
  2. Bio-Pharma Manufacturers
    1. By Value
  3. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
    1. By Value
  4. Hospitals & Clinical-Trial Sites
    1. By Value
  5. Other End Users
    1. By Value
5. By Temperature Range
  1. Introduction
    1. Temperature Range By Value
  2. Cold Chain
    1. By Value
    2. Ambient (15-25 °C)
      1. Ambient (15-25 °C) By Value
    3. Refrigerated (2–8 °C)
      1. Refrigerated (2–8 °C) By Value
    4. Frozen (0 °C to -20 °C)
      1. Frozen (0 °C to -20 °C) By Value
    5. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      1. Ultra-Cold / Cryogenic (-20 °C to -150 °C) By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Service
1. Introduction
  1. Service By Value
2. Transportation
  1. By Value
  2. Road
    1. Road By Value
  3. Air
    1. Air By Value
  4. Others
    1. Others By Value
3. Warehousing & Distribution
  1. By Value
4. Value-Added Services (Labelling, Kitting, QP Release)
  1. By Value
By Clinical Phase
1. Introduction
  1. Clinical Phase By Value
2. Phase I
  1. By Value
3. Phase II
  1. By Value
4. Phase III
  1. By Value
5. Phase IV / post-marketing
  1. By Value
By Therapeutic Area
1. Introduction
  1. Therapeutic Area By Value
2. Oncology
  1. By Value
3. Cardiovascular Diseases
  1. By Value
4. Rare / Orphan Diseases
  1. By Value
5. Immunology & Inflammation
  1. By Value
6. Endocrine & Metabolic Disorders
  1. By Value
7. Neurology & Psychiatry
  1. By Value
8. Others
  1. By Value
By End-user
1. Introduction
  1. End-user By Value
2. Bio-Pharma Manufacturers
  1. By Value
3. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
  1. By Value
4. Hospitals & Clinical-Trial Sites
  1. By Value
5. Other End Users
  1. By Value
By Temperature Range
1. Introduction
  1. Temperature Range By Value
2. Cold Chain
  1. By Value
  2. Ambient (15-25 °C)
    1. Ambient (15-25 °C) By Value
  3. Refrigerated (2–8 °C)
    1. Refrigerated (2–8 °C) By Value
  4. Frozen (0 °C to -20 °C)
    1. Frozen (0 °C to -20 °C) By Value
  5. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    1. Ultra-Cold / Cryogenic (-20 °C to -150 °C) By Value
Brazil
1. By Service
  1. Introduction
    1. Service By Value
  2. Transportation
    1. By Value
    2. Road
      1. Road By Value
    3. Air
      1. Air By Value
    4. Others
      1. Others By Value
  3. Warehousing & Distribution
    1. By Value
  4. Value-Added Services (Labelling, Kitting, QP Release)
    1. By Value
2. By Clinical Phase
  1. Introduction
    1. Clinical Phase By Value
  2. Phase I
    1. By Value
  3. Phase II
    1. By Value
  4. Phase III
    1. By Value
  5. Phase IV / post-marketing
    1. By Value
3. By Therapeutic Area
  1. Introduction
    1. Therapeutic Area By Value
  2. Oncology
    1. By Value
  3. Cardiovascular Diseases
    1. By Value
  4. Rare / Orphan Diseases
    1. By Value
  5. Immunology & Inflammation
    1. By Value
  6. Endocrine & Metabolic Disorders
    1. By Value
  7. Neurology & Psychiatry
    1. By Value
  8. Others
    1. By Value
4. By End-user
  1. Introduction
    1. End-user By Value
  2. Bio-Pharma Manufacturers
    1. By Value
  3. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
    1. By Value
  4. Hospitals & Clinical-Trial Sites
    1. By Value
  5. Other End Users
    1. By Value
5. By Temperature Range
  1. Introduction
    1. Temperature Range By Value
  2. Cold Chain
    1. By Value
    2. Ambient (15-25 °C)
      1. Ambient (15-25 °C) By Value
    3. Refrigerated (2–8 °C)
      1. Refrigerated (2–8 °C) By Value
    4. Frozen (0 °C to -20 °C)
      1. Frozen (0 °C to -20 °C) By Value
    5. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      1. Ultra-Cold / Cryogenic (-20 °C to -150 °C) By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Clinical Trial Logistics Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Arvato SE
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Eurofins Scientific
Almac Group
Thermo Fisher Scientific Inc.
MARKEN
DHL Group
Parexel International (MA) Corporation
Catalent, Inc
PCI
Cencora, inc.
FedEx
Kuehne+Nagel
Biocair
Movianto
Caprihans India Limited
Others

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment